1. BMY will announce Q2 2025 results on July 31, 2025. 2. A conference call will review financial results at 8:00 a.m. ET. 3. Investors can listen live and access materials online. 4. Webcast replay available three hours post-call. 5. BMY aims to transform patients' lives through innovative medicines.
The announcement of Q2 results typically does not precede significant market movements without prior insights. Historical data show mixed reactions to scheduled earnings calls depending on prior performance indicators.
The scheduled earnings announcement may affect short-term trading but lacks major catalysts for high volatility. Anticipation around earnings and future guidance is critical for BMY’s stock movement.
Immediate concerns will arise as investors prepare for Q2 earnings; however, long-term effects will depend on disclosed results.
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2025 on Thursday, July 31, 2025. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call.
A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.
About Bristol Myers Squibb: Transforming Patients’ Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.
corporatefinancial-news